| Dr Nikolas Golosow, MD | |
|
5500 S Sycamore St, Suite 200, Littleton, CO 80120-8201 | |
| (303) 723-4296 | |
| (303) 996-1047 |
| Full Name | Dr Nikolas Golosow |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 5500 S Sycamore St, Littleton, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609977040 | NPI | - | NPPES |
| 01273986 | Medicaid | CO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 27398 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nikolas Golosow, MD 3253 Red Tree Pl, Castle Rock, CO 80104-2716 Ph: (303) 688-8080 | Dr Nikolas Golosow, MD 5500 S Sycamore St, Suite 200, Littleton, CO 80120-8201 Ph: (303) 723-4296 |
News Archive
Virologists from the Katholieke Universiteit Leuven in Belgium report that chloroquine, a widely used antimalarial drug, exhibits antiviral activity against the SARS coronavirus. Chloroquine is an inexpensive and safe drug available worldwide.
GlaxoSmithKline (GSK) is under Food and Drug Administration (FDA) scrutiny again. This is for its diabetes pill Avandia which is under review for the second time in three years.
Water shortages that could reduce food production and worsen economic conditions in Asia are worsening, Arjun Thapan, an infrastructure advisor with the Asian Development Bank (ADB), said on Tuesday at the ADB's Water: Crisis and Choices conference in Manila, Philippines, Agence France-Presse reports.
Clasado Biosciences Limited, the producers and suppliers of the second generation prebiotic Bimuno(R) (B-GOS), a unique trans-galactooligosaccharide, and the Department of Psychiatry, University of Oxford, today announce the results of their latest pre-clinical study demonstrating a major role of the unique carbohydrate complex Bimuno against neuro-inflammation and anxiety.
ACCESS PHARMACEUTICALS, INC., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into an agreement with a major pharmaceutical company to exploit its CobaCyte and CobOral technology for the targeted delivery of RNAi therapeutics.
› Verified 1 days ago
Dr. Christina Peragine, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5984 S Prince St Ste 101, Littleton, CO 80120 Phone: 303-738-1021 Fax: 303-738-1047 | |
Lindsey Dianne Rutledge, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 8340 Sangre De Cristo Rd, Suite 209, Littleton, CO 80127 Phone: 720-589-0528 | |
Dr. James Robert Digioia, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1510 W Canal Ct Ste 2500, Littleton, CO 80120 Phone: 303-338-4545 | |
Dr. Michael Anthony Leander Johnson, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4 W Dry Creek Cir Ste 150, Littleton, CO 80120 Phone: 303-730-2883 Fax: 303-730-2471 | |
Dr. John Frazier Alston, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 5921 Middlefield Rd Ste 201, Littleton, CO 80123 Phone: 303-916-5097 | |
Dr. Mihaela G Alexander, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4 W Dry Creek Cir, Ste 150, Littleton, CO 80120 Phone: 303-730-2883 Fax: 303-730-2471 | |
Shefali Jindal, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 5500 S Sycamore St, Littleton, CO 80120 Phone: 303-730-8858 |